December 16, 2025

Saturated Fat Benefits Vary by Risk

New systematic review finds cardiovascular benefits only in high-risk patients, challenges blanket dietary restrictions

Conexiant

December 15, 2025

PSVT Drug Approved for First Time in Decades

A self-administered intranasal calcium channel blocker enables treatment outside emergency department settings for acute paroxysmal supraventricular tachycardia episodes.

Conexiant

December 12, 2025

Nine Breakthrough Studies Define 2025 Research

From GLP-1 cardioprotection to genome sequencing in newborns, this year's top research spans critical clinical frontiers.

Conexiant

December 10, 2025

Report Looks at the Impact of High Altitude on Healthy Males 

After moving to high altitudes above 4,300 meters, 2 previously healthy young men with normal cardiopulmonary function developed high-altitude pulmonary hypertension

Conexiant

December 08, 2025

The Case of the Hospital That Isn’t

A bureaucratic showdown over North Carolina’s certificate-of-need laws has stalled a critical hospital project, straining care in the state’s mountain communities.

Conexiant

December 04, 2025

BMI Changes Linked to Adult CHD

Swedish cohort shows weight normalization before young adulthood is associated with coronary disease risk comparable to peers with lifelong normal weight.

Conexiant

December 04, 2025

HHS Communications in Transition

Why HHS messaging is shifting, and what it means for patient trust.

KFF Health News

November 25, 2025

ACP Calls for Managed Care Reform

Position paper targets prior authorization burdens, network inadequacy as enrollment surges across Medicare, Medicaid, and commercial insurance.

Conexiant

November 24, 2025

Oral PCSK9 Inhibitor Tied to LDL-C Drop

The oral PCSK9 inhibitor enlicitide decanoate achieved 58% LDL-C reduction in patients with heterozygous familial hypercholesterolemia, offering a potential alternative to injectable therapies.

Conexiant